Minor
ITI-1284 as an Adjunctive Treatment · Generalized Anxiety Disorder
Study completion pushed from Mar 23, 2027 to Oct 21, 2027
Intra-Cellular Therapies, Inc.Phase 2 NCT06480383 Registry history of NCT06480383 on ClinicalTrials.gov (opens the registry)